|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
1441447 |
| 003 |
ICU |
| 005 |
19970809111900.0 |
| 008 |
930318s1992 nyua b 001 0 eng |
| 010 |
|
|
|a 92017708
|
| 020 |
|
|
|a 0824786998
|
| 035 |
|
|
|a (ICU)BID16863479
|
| 035 |
|
|
|a (OCoLC)25964640
|
| 040 |
|
|
|c DLC
|d DLC$dOrLoB
|
| 050 |
0 |
0 |
|a QR189.2
|b .R43 1992
|
| 082 |
|
|
|a 615/.372
|2 20
|
| 245 |
0 |
0 |
|a Recombinant DNA vaccines :
|b rationale and strategy /
|c edited by Richard E. Issacson.
|
| 260 |
|
|
|a New York :
|b Marcel Dekker,
|c c1992.
|
| 300 |
|
|
|a xiv, 409 p. :
|b ill. ;
|c 24 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
0 |
|t Introduction /
|r Gary K. Schoolnik --
|g Pt. 1.
|t Rationale.
|g 1.
|t The Rationale for rDNA Vaccines /
|r Richard E. Isaacson.
|g 2.
|t Modern Approaches to the Development of Attenuated Virus Strains /
|r Anne Flamand.
|g 3.
|t Development of Nontoxic Immunogenic Analogs of Toxins for Vaccines with Emphasis on Pertussis Toxin /
|r James L. Cowell, Robert A. Deich and Alan Kimura.
|g 4.
|t Bacterial Virulence as Strategies to Develop Vaccines /
|r Steven Clegg.
|g 5.
|t Phase and Antigenic Variation of Bacterial Colonization Factors in the Development of Recombinant Vaccines /
|r Barry I. Eisenstein, J. Michael Koomey and Per Klemm.
|g 6.
|t Antigenic Variation in Parasitic Protozoa /
|r C. M. R. Turner.
|g 7.
|t Strategies to Achieve Mucosal Immunity /
|r David F. Keren and Lawrence K. Silbart --
|g Pt. 2.
|t Strategy.
|g 8.
|t Cloning Strategies in Prokaryotes /
|r John F. Barrett and Richard E. Isaacson.
|g 9.
|t The Utility of Fusion Proteins in the Development of Vaccines /
|r Egon Amann.
|g 10.
|t Vaccinia Virus as a Cloning and Delivery System for Vaccines /
|r Michael Mackett.
|g 11.
|t Baculovirus Expression Vectors /
|r Donald L. Jarvis and Max D. Summers.
|g 12.
|t Use of Attenuated Bacteria as Live Oral Vaccine Vectors /
|r John D. Clements, Jian Xiong Bao and Lucia Cardenas.
|g 13.
|t Minicells as Specialized Vaccines and Vaccine Carriers /
|r George G. Khachatourians.
|g 14.
|t Rationale for the Design of Anti-Idiotypic Antibody Vaccines /
|r Sybille Muller, Heinz Kohler and Darrell Anderson.
|g 15.
|t The Iscom--An Approach to Subunit Vaccines /
|r Bror Morein and Lennart Akerblom.
|g 16.
|t Safety of Recombinant Vaccines /
|r Edwin C. Hahn.
|
| 650 |
|
0 |
|a Synthetic vaccines
|0 http://id.loc.gov/authorities/subjects/sh88007866
|
| 650 |
|
0 |
|a Recombinant DNA
|0 http://id.loc.gov/authorities/subjects/sh85111851
|
| 650 |
|
7 |
|a Recombinant DNA.
|2 fast
|0 http://id.worldcat.org/fast/fst01091466
|
| 650 |
|
7 |
|a Synthetic vaccines.
|2 fast
|0 http://id.worldcat.org/fast/fst01141286
|
| 700 |
1 |
0 |
|a Isaacson, Richard E.,
|d 1947-
|0 http://id.loc.gov/authorities/names/n92050561
|1 http://viaf.org/viaf/112864511
|
| 850 |
|
|
|a ICU
|
| 901 |
|
|
|a ToCBNA
|
| 903 |
|
|
|a HeVa
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i 0b10a8a8-0763-57bc-a6fb-86c1a773c392
|s 0ccf81e2-d978-52d6-b789-5094daa5c3e2
|
| 928 |
|
|
|t Library of Congress classification
|a QR189.2.R430 1992
|l JCL
|c JCL-Sci
|i 2866406
|
| 927 |
|
|
|t Library of Congress classification
|a QR189.2.R430 1992
|l JCL
|c JCL-Sci
|e CRERAR
|b 37115150
|i 2815059
|
